Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HUGroup Holdings ( (JP:4544) ) has provided an update.
H.U. Group Holdings reported a notable turnaround in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 2.6% to ¥243,025 million and a return to profitability with a profit attributable to owners of the parent at ¥2,761 million. This marks a significant recovery from the previous fiscal year’s losses, indicating improved operational efficiency and market conditions. The company also forecasts continued growth in the fiscal year ending March 31, 2026, with expected increases in net sales and profits, reflecting a positive outlook for stakeholders.
The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.
More about HUGroup Holdings
H.U. Group Holdings, Inc. is listed on the Tokyo Stock Exchange and operates in the healthcare industry, focusing on providing medical and clinical testing services. The company is known for its comprehensive healthcare solutions and has a significant market presence in Japan.
Average Trading Volume: 203,663
Technical Sentiment Signal: Buy
Current Market Cap: Yen162.6B
Find detailed analytics on 4544 stock on TipRanks’ Stock Analysis page.